The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes — Stella

Home/Type 1 Diabetes/

View on ClinicalTrials.gov

Recruiting

Back to Type 1 Diabetes trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Denmark

Gentofte Hospital, Hellerup

Key details

Sponsor

Asger Lund, MD

Enrollment target

~12 participants

Started

January 2026

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Sex

Male only

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.